![]() |
![]() |
![]() |
![]() |
|
![]() |
As American companies barrel towards ever-increasing use of genetically modified organisms (GMOs) in foods, Europeans are taking a more cautious approach, saying not enough is known about the effects of GMOs, explained Noëlle Lenoir, who was Frances first female Supreme Court justice and is current chair of the European Group on Ethics in Science and New Technologies of the European Union (EU). As the former president of the UNESCO International Committee on Bioethics, Lenoir also wrote the UNESCO Universal Declaration on Human Rights and the Human Genome, later adopted by the United Nations. Lenoir lectured on "Is Biotech a Public Health Concern? The European Perspective" to HSPH members on Wednesday, April 25 in Kresge G-2.
The typical European believes that science needs to be managed to be good for individuals as well as society as a whole, said Lenoir. For Europeans, already facing food crises of mad cow disease and hoof-and-mouth disease in cattle, the thought of genetically tinkering with otherwise perfectly fine food is, well, unpalatable. Its not just a matter of taste. European officials are guided by the so-called "precautionary principle," formally adopted by the European Parliament last year. The principle "may be invoked whenever, as a result of incomplete, inconclusive or uncertain scientific information, there are reasonable grounds for concern at the possible occurrence of effects which are potentially dangerous to the environment or human, animal or plant health," according to European Parliament documents. The principle reflects European officials vulnerability to increasing numbers of lawsuits brought against them by private citizens. Europeans tend to sue their governments when their safety is at risk, said Lenoir, and, she added, the right to the protection of health is constitutionally valid in Europe. If officials gave the greenlight to a new technology that affects a staple such as foodand things go awryEuropean courts would bustle. European farmers are also categorically unenthusiastic about GMOs and have done little to incorporate them into their crops. They "are not so keen to promote biotechnology," said Lenoir. As a result, American food companies have become the biggest promoters of GMOs in Europe. The cautious stance does not forever exclude the possibility of GMO use in European foods. Many government officials think that biotechnology is not as risky as some critics charge, said Lenoir, but they also are aware of public opinion that calls for measured steps. "We have to try to find common ground that considers risk assessment and science and that includes peoples opinions from the beginning," said Lenoir. Harvard Public Health NOW is published biweekly by the Office of Communications Harvard School of Public Health 665 Huntington Ave., SPH 1-1204 Boston, Massachusetts 02115 617-432-6052 Editor: Christina Roache Photos Credits: Christina Roache, Richard Chase, McGraw-Hill Archived Issues || HSPH Home Copyright, 2009, President and Fellows of Harvard College |